Literature DB >> 25460152

A novel aerosol generator for homogenous distribution of powder over the lungs after pulmonary administration to small laboratory animals.

Wouter F Tonnis, Marieke Bagerman, Michel Weij, Jelmer Sjollema, Henderik W Frijlink, Wouter L J Hinrichs, Anne H de Boer.   

Abstract

To evaluate powder formulations for pulmonary administration in pre-clinic research, the powder should be administered to the lungs of small laboratory animals. To do so properly, a device is needed that generates particles small enough to reach deep into the lungs. In this study a newly developed aerosol generator was tested for pulmonary administration of powder to the lungs of mice and its performance was compared to the only currently available device, the Penn-Century insufflator. Results showed that both devices generated powder particles of approximately the same size distribution, but the fine particle fraction needed for deep lung administration was strongly improved when the aerosol generator was used.Imaging studies in mice showed that powder particles from the aerosol generator deposited into the deep lung, where powder from the Penn-Century insufflator did not reach further than the conducting airways.Furthermore, powder administered by using the aerosol generator was more homogenously distributed over the five individual lungs lobes than powder administrated by using the Penn-Century insufflator.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25460152     DOI: 10.1016/j.ejpb.2014.10.011

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.

Authors:  Susan Boc; Mohammad A M Momin; Dale R Farkas; Worth Longest; Michael Hindle
Journal:  AAPS PharmSciTech       Date:  2021-04-15       Impact factor: 3.246

Review 2.  Influence of physical properties of carrier on the performance of dry powder inhalers.

Authors:  Tingting Peng; Shiqi Lin; Boyi Niu; Xinyi Wang; Ying Huang; Xuejuan Zhang; Ge Li; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2016-05-04       Impact factor: 11.413

3.  In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.

Authors:  Dominique N Price; Loreen R Stromberg; Nitesh K Kunda; Pavan Muttil
Journal:  Mol Pharm       Date:  2017-11-09       Impact factor: 4.939

4.  PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection.

Authors:  Putri D Utari; Rita Setroikromo; Barbro N Melgert; Wim J Quax
Journal:  Front Cell Infect Microbiol       Date:  2018-04-26       Impact factor: 5.293

5.  Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination.

Authors:  Jasmine Tomar; Wouter F Tonnis; Harshad P Patil; Anne H de Boer; Paul Hagedoorn; Rita Vanbever; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Acta Pharm Sin B       Date:  2019-05-28       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.